A Phase 1, Open-label Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Tivozanib in Healthy Subjects

Trial Profile

A Phase 1, Open-label Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Tivozanib in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2012

At a glance

  • Drugs Ketoconazole; Tivozanib
  • Indications Cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 04 Jun 2012 Last checked against ClinicalTrials.gov record.
    • 04 Jun 2012 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
    • 04 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top